You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
香雪製藥(300147.SZ)擬將香雪藥業100%股權無償劃轉至香雪智慧中醫藥產業
格隆匯 01-16 20:14

格隆匯1月16日丨香雪製藥(300147.SZ)公佈,為進一步優化整合公司內部資源,提升公司資產配置及業務的專業化管理,公司將下屬全資子公司廣東香雪藥業有限公司(“香雪藥業”)100%股權按賬面值無償劃轉至公司全資子公司廣東香雪智慧中醫藥產業有限公司。

廣東香雪藥業有限公司經營範圍:許可經營項目:片劑(含激素類),硬膠囊劑(含頭孢菌素類),小容量注射劑(含抗腫瘤類),凍乾粉針劑(含抗腫瘤類),原料藥。

此次股權劃轉有利於優化資源配置,提高運營效率,有利於公司整體業績提升。此次交易完成後,公司合併報表範圍未發生變化,對公司的正常經營、財務狀況和經營成果不產生重大影響,不存在損害公司及股東利益的情形。公司將根據上述事項的進展情況,及時履行信息披露義務,敬請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account